Back to Agenda
EXTRAPOLATION
Session Chair(s)
Sabine Atzor, MPharm, RPh
Head of EU Regulatory Policies
F. Hoffmann-La Roche Ltd, Switzerland
Speaker(s)
Elena Wolff-Holz, MD, PhD
Paul-Ehrlich Institut, Germany
Chair, Biosimilar Medicinal Products Working Party (BMWP) of CHMP; Assessor
Quality Considerations of Biosimilars
Virginia Acha, PhD, MSc
Merck Sharp & Dohme LLC, United Kingdom
AVP, Global Regulatory Policy
Michael Reilly, JD, MD
Alliance For Safe Biologic Medicines, United States
Executive Director
Traceability of biosimilars and INN Debate
Lisette Vromans
Merck Sharp & Dohme, Netherlands
Ass Director Regulatory Liaison Regulatory policy EU & MOW
Have an account?